Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of bryostatin-1 in treating patients with recurrent
non-Hodgkin's lymphoma. Drugs used in chemotherapy use different ways to stop cancer cells
from dividing so they stop growing or die.